Lynne Deans
About Lynne Deans
Lynne Deans serves as the Vice President of Clinical Development at Aridis Pharmaceuticals, bringing over 30 years of experience in clinical research. She has held various leadership roles in clinical operations at companies such as Dermira, Inc., Kalobios Inc., and Roche, contributing to multiple FDA approvals in diverse therapeutic areas.
Current Role at Aridis Pharmaceuticals
Lynne Deans serves as the Vice President of Clinical Development at Aridis Pharmaceuticals. She has held this position since 2018, contributing to the company's clinical strategies and operations. Her role involves overseeing clinical trials and ensuring compliance with regulatory requirements. With a focus on advancing therapeutic innovations, she plays a key part in the development of new treatments.
Previous Experience at Dermira, Inc.
Prior to her current position, Lynne Deans worked at Dermira, Inc. as the Senior Director of Clinical Operations from 2013 to 2021. During her eight years at Dermira, she managed clinical trial operations and contributed to the development of therapies in dermatology. Her leadership in clinical operations helped facilitate the progression of multiple projects through various phases of development.
Clinical Operations Experience
Lynne Deans has extensive experience in clinical operations, having held senior roles at several organizations. She was the Senior Director of Clinical Operations at Kalobios Inc. for one year and at PaxVax, Inc. for two years. Additionally, she served as the Director of Clinical Operations and Department Head at Roche from 1999 to 2002. This diverse background has provided her with a comprehensive understanding of clinical research processes.
Expertise in Therapeutic Areas
Lynne Deans possesses expertise in various therapeutic areas, including vaccines, Alzheimer's disease, pain management, and transplant medicine. Her knowledge in these fields has informed her work in clinical development and has been instrumental in advancing clinical trials aimed at addressing significant health challenges.
Educational Background
Lynne Deans studied at James Madison University, where she achieved a degree in Medical Technology. This educational foundation has supported her extensive career in clinical research, providing her with the necessary skills and knowledge to excel in her roles within the pharmaceutical industry.
Contributions to FDA Approvals
Throughout her career, Lynne Deans has contributed to four FDA approvals across various fields, including Infectious Disease, Neurology, and Dermatology. Her involvement in these projects highlights her significant role in the clinical development process and her commitment to advancing healthcare solutions.